Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,346 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma.
Uramoto H, Shimokawa H, Hanagiri T, Kuwano M, Ono M. Uramoto H, et al. Among authors: ono m. Lung Cancer. 2011 Sep;73(3):361-5. doi: 10.1016/j.lungcan.2011.01.008. Epub 2011 Feb 18. Lung Cancer. 2011. PMID: 21315472
ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase.
Hirata A, Ogawa S, Kometani T, Kuwano T, Naito S, Kuwano M, Ono M. Hirata A, et al. Among authors: ono m. Cancer Res. 2002 May 1;62(9):2554-60. Cancer Res. 2002. PMID: 11980649
The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies.
Kuwano M, Uchiumi T, Hayakawa H, Ono M, Wada M, Izumi H, Kohno K. Kuwano M, et al. Among authors: ono m. Cancer Sci. 2003 Jan;94(1):9-14. doi: 10.1111/j.1349-7006.2003.tb01344.x. Cancer Sci. 2003. PMID: 12708467 Review.
Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Ono M, Hirata A, Kometani T, Miyagawa M, Ueda S, Kinoshita H, Fujii T, Kuwano M. Ono M, et al. Mol Cancer Ther. 2004 Apr;3(4):465-72. Mol Cancer Ther. 2004. PMID: 15078990
Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839).
Hirata A, Uehara H, Izumi K, Naito S, Kuwano M, Ono M. Hirata A, et al. Among authors: ono m. Cancer Sci. 2004 Jul;95(7):614-8. doi: 10.1111/j.1349-7006.2004.tb02496.x. Cancer Sci. 2004. PMID: 15245600
HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells.
Hirata A, Hosoi F, Miyagawa M, Ueda S, Naito S, Fujii T, Kuwano M, Ono M. Hirata A, et al. Among authors: ono m. Cancer Res. 2005 May 15;65(10):4253-60. doi: 10.1158/0008-5472.CAN-04-2748. Cancer Res. 2005. PMID: 15899817
Cooperative cell-growth inhibition by combination treatment with ZD1839 (Iressa) and trastuzumab (Herceptin) in non-small-cell lung cancer.
Nakamura H, Takamori S, Fujii T, Ono M, Yamana H, Kuwano M, Shirouzu K. Nakamura H, et al. Among authors: ono m. Cancer Lett. 2005 Dec 8;230(1):33-46. doi: 10.1016/j.canlet.2004.12.020. Epub 2005 Jan 20. Cancer Lett. 2005. PMID: 16253759
PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib.
Ueda S, Basaki Y, Yoshie M, Ogawa K, Sakisaka S, Kuwano M, Ono M. Ueda S, et al. Among authors: ono m. Cancer Res. 2006 May 15;66(10):5346-53. doi: 10.1158/0008-5472.CAN-05-3684. Cancer Res. 2006. PMID: 16707461
Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, Aoyagi S, Kinoshita H, Kuwano M. Maruyama Y, et al. Among authors: ono m. Cancer Res. 2006 Jun 15;66(12):6233-42. doi: 10.1158/0008-5472.CAN-06-0183. Cancer Res. 2006. PMID: 16778198
High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma.
Aishima S, Basaki Y, Oda Y, Kuroda Y, Nishihara Y, Taguchi K, Taketomi A, Maehara Y, Hosoi F, Maruyama Y, Fotovati A, Oie S, Ono M, Ueno T, Sata M, Yano H, Kojiro M, Kuwano M, Tsuneyoshi M. Aishima S, et al. Among authors: ono m. Cancer Sci. 2006 Nov;97(11):1182-90. doi: 10.1111/j.1349-7006.2006.00322.x. Epub 2006 Sep 12. Cancer Sci. 2006. PMID: 16965600
3,346 results
Jump to page
Feedback